Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study

2020 . Hochhaus, Andreas | Gambacorti-Passerini, Carlo | Abboud, Camille | Gjertsen, Bjørn Tore | Brümmendorf, Tim H. | Smith, B. Douglas | Ernst, Thomas | Giraldo-Castellano, Pilar | Olsson-Strömberg, Ulla | Saussele, Susanne | Bardy-Bouxin, Nathalie | Viqueira, Andrea | Leip, Eric | Russell-Smith, T. Alexander | Leone, Jocelyn | Rosti, Gianantonio | Watts, Justin | Giles, Francis J. | Abruzzese, E. | Akard, L. P. | Bosi, A. | Cervantes, F. | Charbonnier, A. | Di Raimondo, F. | Etienne, G. | Garcia Gutierrez, V. | Guerci-Bresler, A. P. | Hjorth-Hansen, H | Karsenti, J. M. | Kelly, K. R. | Le Coutre, P. | Martinez Chamorro, C. | Oehler, V. G. | Orti Pascual, G. | Petzer, A. | Pungolino, E. | Rege-Cambrin, G. | Rigal-Huguet, F. | Roboz, G. J. | Rousselot, P. | Sanchez-Guijo, F. M. | Sanz Santillana, G. | Schafhausen, P. | Scheid, C. | Schmidt, S. | Specchia, G. | Steegmann, J. L. | Stenke, L.